Nationales Centrum für Tumorerkrankungen (NCT)

Research facility

Location: Heidelberg, Dresden, Berlin, Essen, Köln, Würzburg, Erlangen, Regensburg, Augsburg, Tübingen, Stuttgart, Ulm, Germany (DE)

ISNI: 0000000088550365

ROR: https://ror.org/01txwsw02

Show on Map:

Publications

(65)

Research Grants

(1)

Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning (2024) Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, et al. Journal article Bewegungsversorgung im deutschen Gesundheitssystem: gesundheitspolitische Relevanz und notwendige Rahmenbedingungen – ein Positionspapier der AG Bewegungsbezogene Versorgungsforschung des DNVF (2024) Schaller A, Thiel C, Peters S, Geidl W, Klamroth S, Lange M, Kastaun S, et al. Journal article Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy (2023) Huober J, van Mackelenbergh M, Schneeweiss A, Seither F, Blohmer JU, Denkert C, Tesch H, et al. Journal article Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma (2023) Han Y, Drobisch P, Krüger A, William D, Grützmann K, Böthig L, Polster H, et al. Journal article Health literacy and information needs among German skin cancer patients in comparison to people without skin cancer: A survey (2023) Hoffmann J, Steeb T, Weber C, Doppler A, Schmitt J, Schadendorf D, Berking C, Meier F Journal article RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial (2023) Link T, Blohmer JU, Schmitt WD, Kuhlmann JD, Just M, Untch M, Stoetzer OJ, et al. Journal article Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial (2023) Williams TM, Schneeweiss A, Jackisch C, Shen C, Weber KE, Fasching P, Denkert C, et al. Journal article Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study (2023) Eichler M, Hentschel L, Singer S, Hornemann B, Richter S, Hofbauer C, Hohenberger P, et al. Journal article Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis (2022) Guyon J, Fernandez-Moncada I, Larrieu CM, Bouchez CL, Pagano Zottola AC, Galvis J, Chouleur T, et al. Journal article A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution

‹ 1 2 3 4 ... 7 ›